Show
10
20
30
40
results per page
COVID-19 Variant Supplement – Peptide macrocycle decoys against COVID‑19 viral spike protein
Perrin, David M |
University of British Columbia | Operating Grant | $50,000
CIHR British Columbia 2021
Read More
Investigating access to and outcomes from supervised drug consumption services in British Columbia before and during the COVID‑19 pandemic
Kerr, Thomas H |
British Columbia Centre on Substance Use | Operating Grant | $249,065
CIHR British Columbia 2021
Read More
A double blind randomized trial of low-dose naltrexone for post-covid fatigue syndrome
Nacul, Luis |
B.C. Women's Hospital | Operating Grant | $742,331
CIHR British Columbia 2021
Read More
COVID-19 Variant Network – Bespoke transition state analog inhibitors of SARS-CoV-2 3CL and PL proteases
Strynadka, Natalie C |
University of British Columbia | Operating Grant | $100,000
CIHR British Columbia 2021
Read More
COVID-19 Variant Supplement – The COVID‑19 Pandemic Among Sexual and Gender Marginalized Populations in Canada: Physical Distancing Impacts, SARS-CoV-2 Seroprevalence, and Health and Wellness Needs
Lachowsky, Nathan J |
University of Victoria | Operating Grant | $50,000
CIHR British Columbia 2021
Read More
Investigating Neuropsychological Consequences of COVID‑19 on Adults, and Examination of Associated Risk and Resilience Factors
Paterson, Theone |
University of Victoria | Operating Grant | $199,121
CIHR British Columbia 2021
Read More
COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics
Haas, Kurt |
University of British Columbia | Operating Grant | $50,000
CIHR British Columbia 2021
Read More
All-cause and cause-specific acute morbidity attributable to Covid-19 epidemic, severe Covid-19 symptoms, and adverse birth outcomes in Canada.
Lisonkova, Sarka |
University of British Columbia | Project Grant | $168,300
CIHR British Columbia 2021
Read More
An Environmental Scan of Service Adaptations in Community-Based Harm Reduction Services for Indigenous Peoples in Response to the COVID‑19 Pandemic
Masching, Renee |
Communities, Alliances & Networks | Other | $100,000
CIHR British Columbia 2021
Read More
COVID-19 Variant Supplement – Bespoke transition state analog inhibitors of SARS-CoV-2 3CL and PL proteases
Strynadka, Natalie C |
University of British Columbia | Operating Grant | $50,000
CIHR British Columbia 2021
Read More